FI20001771A - Indolderivat som steroid-5alfa-reduktasinhibitorer - Google Patents

Indolderivat som steroid-5alfa-reduktasinhibitorer Download PDF

Info

Publication number
FI20001771A
FI20001771A FI20001771A FI20001771A FI20001771A FI 20001771 A FI20001771 A FI 20001771A FI 20001771 A FI20001771 A FI 20001771A FI 20001771 A FI20001771 A FI 20001771A FI 20001771 A FI20001771 A FI 20001771A
Authority
FI
Finland
Prior art keywords
pct
steroid
reductase inhibitors
indole derivatives
alpha reductase
Prior art date
Application number
FI20001771A
Other languages
English (en)
Finnish (fi)
Inventor
Graham Nigel Maw
Julian Blagg
Colin William Greengrass
Paul William Finn
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI20001771A publication Critical patent/FI20001771A/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI20001771A 1992-02-28 2000-08-09 Indolderivat som steroid-5alfa-reduktasinhibitorer FI20001771A (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929204365A GB9204365D0 (en) 1992-02-28 1992-02-28 Indoles
PCT/EP1993/000380 WO1993017014A1 (en) 1992-02-28 1993-02-16 Indole derivatives as steroid 5 alpha-reductase inhibitors

Publications (1)

Publication Number Publication Date
FI20001771A true FI20001771A (sv) 2000-08-09

Family

ID=10711259

Family Applications (2)

Application Number Title Priority Date Filing Date
FI943931A FI943931A (sv) 1992-02-28 1994-08-26 Indolderivat som steroid-5alfa-reduktasinhibitorer
FI20001771A FI20001771A (sv) 1992-02-28 2000-08-09 Indolderivat som steroid-5alfa-reduktasinhibitorer

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FI943931A FI943931A (sv) 1992-02-28 1994-08-26 Indolderivat som steroid-5alfa-reduktasinhibitorer

Country Status (24)

Country Link
US (1) US5767139A (sv)
EP (1) EP0628040B1 (sv)
JP (1) JP2540016B2 (sv)
KR (1) KR950700287A (sv)
CN (1) CN1079465A (sv)
AT (1) ATE164376T1 (sv)
AU (1) AU3497793A (sv)
BR (1) BR9305991A (sv)
CA (1) CA2117610C (sv)
CZ (1) CZ207794A3 (sv)
DE (1) DE69317651T2 (sv)
DK (1) DK0628040T3 (sv)
ES (1) ES2115053T3 (sv)
FI (2) FI943931A (sv)
GB (1) GB9204365D0 (sv)
HR (1) HRP930227A2 (sv)
HU (1) HUT71126A (sv)
IL (1) IL104816A0 (sv)
MX (1) MX9301112A (sv)
NO (1) NO943187L (sv)
RU (1) RU94042391A (sv)
SK (1) SK100894A3 (sv)
WO (1) WO1993017014A1 (sv)
ZA (1) ZA931383B (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL109728A0 (en) * 1993-05-28 1994-08-26 Pfizer Res & Dev Indoles
ES2099007B1 (es) * 1993-07-16 1997-12-01 Pfizer Res & Dev Derivados de indol.
GB9317096D0 (en) * 1993-08-17 1993-09-29 Pfizer Ltd Indoles
GB9403516D0 (en) * 1994-02-24 1994-04-13 Pfizer Ltd Indoles
GB9409583D0 (en) * 1994-05-13 1994-07-06 Pfizer Ltd Indoles
KR100430059B1 (ko) * 1995-04-10 2004-09-24 후지사와 야꾸힝 고교 가부시키가이샤 cGMP-PDE억제제로서의인돌유도체
WO2000007590A1 (en) * 1998-08-03 2000-02-17 Eli Lilly And Company INDOLE sPLA2 INHIBITORS
FR2796279B1 (fr) 1999-07-16 2001-09-21 Oreal Utilisation de l'acide 4,6-dimethoxy-indole 2-carboxylique ou de ses derives pour le traitement de la seborrhee
FR2796274B1 (fr) * 1999-07-16 2001-09-21 Oreal Utilisation de l'acide 4,6-dimethoxy-indole 2-carboxylique ou de ses derives pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
UA79504C2 (en) * 2002-11-07 2007-06-25 Organon Nv Indols for treating diseases associated with androgen receptors
KR20050072812A (ko) * 2002-11-07 2005-07-12 악조 노벨 엔.브이. 안드로겐-수용체와 관련된 질병의 치료에 효과적인 인돌
TW200602317A (en) 2004-04-23 2006-01-16 Akzo Nobel Nv Novel androgens
GB201102913D0 (en) 2011-02-18 2011-04-06 Univ Birmingham Novel therapeutic

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3557142A (en) * 1968-02-20 1971-01-19 Sterling Drug Inc 4,5,6,7-tetrahydro-indole-lower-alkanoic acids and esters
PH23498A (en) * 1984-08-06 1989-08-16 Sterling Drug Inc 3-carbonyl-1-aminoalkyl-1h-indoles,composition and use thereof
CA2036307C (en) * 1990-03-08 2002-07-09 Susan Jean Ward 3-arylcarbonyl-1-aminoalkyl-1h-indole-containing antiglaucoma compositions and method
GB9011335D0 (en) * 1990-05-21 1990-07-11 Fujisawa Pharmaceutical Co Indolebutyric acid derivatives and process for preparation thereof
IL109728A0 (en) * 1993-05-28 1994-08-26 Pfizer Res & Dev Indoles

Also Published As

Publication number Publication date
IL104816A0 (en) 1993-06-10
EP0628040B1 (en) 1998-03-25
JP2540016B2 (ja) 1996-10-02
EP0628040A1 (en) 1994-12-14
FI943931A0 (sv) 1994-08-26
MX9301112A (es) 1994-07-29
DK0628040T3 (da) 1998-04-27
CA2117610A1 (en) 1993-09-02
ZA931383B (en) 1994-08-26
ES2115053T3 (es) 1998-06-16
RU94042391A (ru) 1996-08-10
CA2117610C (en) 2000-07-18
JPH07500347A (ja) 1995-01-12
NO943187D0 (no) 1994-08-29
SK100894A3 (en) 1995-04-12
HUT71126A (en) 1995-11-28
CN1079465A (zh) 1993-12-15
KR950700287A (ko) 1995-01-16
US5767139A (en) 1998-06-16
NO943187L (no) 1994-09-13
AU3497793A (en) 1993-09-13
WO1993017014A1 (en) 1993-09-02
HRP930227A2 (en) 1996-10-31
ATE164376T1 (de) 1998-04-15
DE69317651T2 (de) 1998-07-09
FI943931A (sv) 1994-08-26
GB9204365D0 (en) 1992-04-08
BR9305991A (pt) 1997-10-21
DE69317651D1 (en) 1998-04-30
HU9402466D0 (en) 1994-10-28
CZ207794A3 (en) 1995-01-18

Similar Documents

Publication Publication Date Title
DK0687251T3 (da) 1,3-dihydroindol-2-on-derivater, der er substitueret i 3-stillingen med en nitrogengruppe, til anvendelse som vasopressin- og/eller ocytocin-agonister og/eller -antagonister
DK0641328T3 (da) Broforbundne, azabicykliske derivater som substans P-antagonister
FI20001771A (sv) Indolderivat som steroid-5alfa-reduktasinhibitorer
MX9303605A (es) Derivados de azabicicloheptano n-substituidas, su obtencion y uso.
IL107520A0 (en) Substituted ortho-ethenylphenylacetic acid derivatives and pharmaceutical compositions containing them
AU3410693A (en) Carbamate derivatives and their use in medicine
FI955707A0 (sv) Indolderivat som steroid 5alfa-reduktasinhibitorer
ES2087567T3 (es) Derivados antibioticos de 7'-amino-naftazarina.
MX9303607A (es) Derivados de azabicicloheptano sustituidos, su obtencion y uso.

Legal Events

Date Code Title Description
MA Patent expired